{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T19:55:59Z","timestamp":1794081359121,"version":"4.8.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,16]],"date-time":"2021-04-16T00:00:00Z","timestamp":1618531200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005690","name":"Universit\u00e4t des Saarlandes","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005690","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Medical Microbiology"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.ijmm.2021.151507","type":"journal-article","created":{"date-parts":[[2021,4,20]],"date-time":"2021-04-20T16:42:52Z","timestamp":1618936972000},"page":"151507","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Molecular epidemiology and antimicrobial resistance of Clostridioides difficile in Germany, 2014\u20132019"],"prefix":"10.1016","volume":"311","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5029-6223","authenticated-orcid":false,"given":"Ahmed Mohamed Mostafa","family":"Abdrabou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zia","family":"Ul Habib Bajwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Halfmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0649-5185","authenticated-orcid":false,"given":"Alexander","family":"Mellmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Nimmesgern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena","family":"Margardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Bischoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lutz","family":"von M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"G\u00e4rtner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9081-597X","authenticated-orcid":false,"given":"Fabian K.","family":"Berger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijmm.2021.151507_bib0005","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.diagmicrobio.2015.05.015","article-title":"A national survey of the molecular epidemiology of Clostridium difficile in Israel: the dissemination of the ribotype 027 strain with reduced susceptibility to vancomycin and metronidazole","volume":"83","author":"Adler","year":"2015","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"10.1016\/j.ijmm.2021.151507_bib0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.anaerobe.2016.04.006","article-title":"Clostridium difficile ribotype 027 is not evenly distributed in Hesse","volume":"40","author":"Arvand","year":"2016","journal-title":"Germany. Anaerobe"},{"key":"10.1016\/j.ijmm.2021.151507_bib0015","doi-asserted-by":"crossref","first-page":"267","DOI":"10.3390\/antibiotics4030267","article-title":"Antimicrobial resistance and reduced susceptibility in Clostridium difficile: potential consequences for induction, treatment, and recurrence of C. difficile infection","volume":"4","author":"Baines","year":"2015","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.ijmm.2021.151507_bib0020","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1128\/JCM.00533-15","article-title":"Clostridium difficile PCR ribotype 018, a successful epidemic genotype","volume":"53","author":"Baldan","year":"2015","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.ijmm.2021.151507_bib0025","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.ijmm.2018.01.004","article-title":"Molecular characterization, toxin detection and resistance testing of human clinical Clostridium difficile isolates from Lebanon","volume":"308","author":"Berger","year":"2018","journal-title":"Int. J. Med. Microbiol."},{"key":"10.1016\/j.ijmm.2021.151507_bib0030","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ijmm.2019.03.001","article-title":"Hospital outbreak due to Clostridium difficile ribotype 018 (RT018) in Southern Germany","volume":"309","author":"Berger","year":"2019","journal-title":"Int. J. Med. Microbiol."},{"key":"10.1016\/j.ijmm.2021.151507_bib0035","article-title":"Quality assurance for genotyping and resistance testing of Clostridium (Clostridioides) difficile isolates - Experiences from the first inter-laboratory ring trial in four German speaking countries","author":"Berger","year":"2019","journal-title":"Anaerobe"},{"key":"10.1016\/j.ijmm.2021.151507_bib0040","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/2047-2994-2-21","article-title":"Epidemiology of Clostridium difficile infection in Asia","volume":"2","author":"Collins","year":"2013","journal-title":"Antimicrob. Resist. Infect. Control"},{"issue":"Suppl 4","key":"10.1016\/j.ijmm.2021.151507_bib0045","doi-asserted-by":"crossref","first-page":"S63","DOI":"10.1016\/j.cmi.2016.03.010","article-title":"European Society of Clinical Microbiology and Infectious Diseases: update of the diagnostic guidance document for Clostridium difficile infection","volume":"22","author":"Crobach","year":"2016","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.ijmm.2021.151507_bib0050","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2016.21.29.30294","article-title":"Diversity of Clostridium difficile PCR ribotypes in Europe: results from the European, multicentre, prospective, biannual, point-prevalence study of Clostridium difficile infection in hospitalised patients with diarrhoea (EUCLID), 2012 and 2013","volume":"21","author":"Davies","year":"2016","journal-title":"Euro Surveill."},{"key":"10.1016\/j.ijmm.2021.151507_bib0055","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1136\/vr.102462","article-title":"Antibiotics used most commonly to treat animals in Europe","volume":"175","author":"De Briyne","year":"2014","journal-title":"Vet. Rec."},{"key":"10.1016\/j.ijmm.2021.151507_bib0060","doi-asserted-by":"crossref","DOI":"10.1111\/vde.12404","article-title":"Rifampicin treatment of canine pyoderma due to multidrug-resistant meticillin-resistant staphylococci: a retrospective study of 32 cases","volume":"28","author":"De Lucia","year":"2017","journal-title":"Vet. Dermatol."},{"key":"10.1016\/j.ijmm.2021.151507_bib0065","series-title":"Clinical breakpoints version 11.0","author":"EUCAST","year":"2021"},{"key":"10.1016\/j.ijmm.2021.151507_bib0070","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s13756-017-0181-4","article-title":"Management of a cluster of Clostridium difficile infections among patients with osteoarticular infections","volume":"6","author":"F\u00e4rber","year":"2017","journal-title":"Antimicrob. Resist. Infect. Control"},{"key":"10.1016\/j.ijmm.2021.151507_bib0075","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1128\/CMR.00082-09","article-title":"The changing epidemiology of Clostridium difficile infections","volume":"23","author":"Freeman","year":"2010","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.ijmm.2021.151507_bib0080","doi-asserted-by":"crossref","unstructured":"Freeman, J., Vernon, J., Pilling, S., Morris, K., Nicholson, S., Shearman, S., Longshaw, C., Wilcox, M.H., Pan-European longitudinal surveillance of antibiotic resistance among prevalent Clostridium difficile ribotypes study group., 2018. The ClosER study: results from a three-year pan-European longitudinal surveillance of antibiotic resistance among prevalent Clostridium difficile ribotypes, 2011-2014. Clin Microbiol Infect 24, 724-731.","DOI":"10.1016\/j.cmi.2017.10.008"},{"key":"10.1016\/j.ijmm.2021.151507_bib0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.anaerobe.2019.102087","article-title":"Local outbreak of Clostridioides difficile PCR-Ribotype 018 investigated by multi locus variable number tandem repeat analysis, whole genome multi locus sequence typing and core genome single nucleotide polymorphism typing","volume":"60","author":"Gateau","year":"2019","journal-title":"Anaerobe"},{"key":"10.1016\/j.ijmm.2021.151507_bib0090","doi-asserted-by":"crossref","first-page":"15","DOI":"10.4161\/gmic.26854","article-title":"Clostridium difficile binary toxin CDT: mechanism, epidemiology, and potential clinical importance","volume":"5","author":"Gerding","year":"2014","journal-title":"Gut Microbes"},{"key":"10.1016\/j.ijmm.2021.151507_bib0095","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.ARBA-0004-2016","article-title":"Antimicrobial resistance in Rhodococcus equi","volume":"5","author":"Giguere","year":"2017","journal-title":"Microbiol. Spectr."},{"key":"10.1016\/j.ijmm.2021.151507_bib0100","first-page":"418","article-title":"[S2k-guideline gastrointestinal infectious diseases and Whipple\u2019s disease]","volume":"53","author":"Hagel","year":"2015","journal-title":"Z. Gastroenterol."},{"key":"10.1016\/j.ijmm.2021.151507_bib0105","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/ng.2478","article-title":"Emergence and global spread of epidemic healthcare-associated Clostridium difficile","volume":"45","author":"He","year":"2013","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ijmm.2021.151507_bib0110","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.anaerobe.2010.09.002","article-title":"Antimicrobial susceptibility and heteroresistance in Chinese Clostridium difficile strains","volume":"16","author":"Huang","year":"2010","journal-title":"Anaerobe"},{"key":"10.1016\/j.ijmm.2021.151507_bib0115","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1080\/22221751.2019.1621670","article-title":"Clostridium difficile ribotype 017 - characterization, evolution and epidemiology of the dominant strain in Asia","volume":"8","author":"Imwattana","year":"2019","journal-title":"Emerg. Microbes Infect."},{"key":"10.1016\/j.ijmm.2021.151507_bib0120","article-title":"Confirmed cases and report of clusters of severe infections due to Clostridium difficile PCR ribotype 027 in Germany","volume":"12","author":"Kleinkauf","year":"2007","journal-title":"Euro Surveill."},{"key":"10.1016\/j.ijmm.2021.151507_bib0125","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2016.21.29.30296","article-title":"Clostridium difficile PCR ribotypes 001 and 176 - the common denominator of C. difficile infection epidemiology in the Czech Republic, 2014","volume":"21","author":"Krutova","year":"2016","journal-title":"Euro Surveill."},{"key":"10.1016\/j.ijmm.2021.151507_bib0130","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/S1473-3099(16)30397-8","article-title":"Effect of a national 4C antibiotic stewardship intervention on the clinical and molecular epidemiology of Clostridium difficile infections in a region of Scotland: a non-linear time-series analysis","volume":"17","author":"Lawes","year":"2017","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.ijmm.2021.151507_bib0135","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s40121-016-0135-9","article-title":"Epidemiology and recurrence rates of Clostridium difficile infections in Germany: a secondary data analysis","volume":"5","author":"L\u00fcbbert","year":"2016","journal-title":"Infect. Dis. Ther."},{"key":"10.1016\/j.ijmm.2021.151507_bib0140","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1093\/cid\/ciy149","article-title":"Clinical practice guidelines for Clostridium difficile infection in adults and children: 2017 update by the infectious diseases society of america (IDSA) and society for healthcare epidemiology of america (SHEA)","volume":"66","author":"McDonald","year":"2018","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ijmm.2021.151507_bib0145","doi-asserted-by":"crossref","first-page":"15023","DOI":"10.1038\/srep15023","article-title":"Clostridium difficile: new insights into the evolution of the pathogenicity locus","volume":"5","author":"Monot","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijmm.2021.151507_bib0150","series-title":"Antibiotikaverbrauch und die Verbreitung von Antibiotikaresistenzen in der Human-und Veterin\u00e4rmedizin in Deutschland","author":"Paul-Ehrlich-Gesellschaft","year":"2015"},{"key":"10.1016\/j.ijmm.2021.151507_bib0155","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1007\/s00284-019-01654-3","article-title":"Changes in Clostridium (Clostridioides) difficilePCR-Ribotype distribution and antimicrobial resistance in a German Tertiary Care Hospital over the last 10 years","volume":"76","author":"Piepenbrock","year":"2019","journal-title":"Curr. Microbiol."},{"key":"10.1016\/j.ijmm.2021.151507_bib0160","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.jinf.2013.07.017","article-title":"Epidemiology of adverse events and Clostridium difficile-associated diarrhea during long-term antibiotic therapy for osteoarticular infections","volume":"67","author":"Schindler","year":"2013","journal-title":"J. Infect."},{"key":"10.1016\/j.ijmm.2021.151507_bib0165","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0139811","article-title":"Tracing the spread of Clostridium difficile ribotype 027 in Germany based on bacterial genome sequences","volume":"10","author":"Steglich","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ijmm.2021.151507_bib0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.anaerobe.2019.06.003","article-title":"Changes in molecular epidemiology and antimicrobial resistance profiles of Clostridioides (Clostridium) difficile strains in the United States between 2011 and 2017","volume":"60","author":"Tickler","year":"2019","journal-title":"Anaerobe"},{"key":"10.1016\/j.ijmm.2021.151507_bib0175","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1111\/1469-0691.12619","article-title":"The Clostridium difficile PCR ribotype 027 lineage: a pathogen on the move","volume":"20","author":"Valiente","year":"2014","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.ijmm.2021.151507_bib0180","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1007\/s00103-012-1556-6","article-title":"[Current data and trends on the development of antibiotic resistance of Clostridium difficile]","volume":"55","author":"von M\u00fcller","year":"2012","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz"},{"key":"10.1016\/j.ijmm.2021.151507_bib0185","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.ijmm.2015.08.035","article-title":"Epidemiology of Clostridium difficile in Germany based on a single center long-term surveillance and German-wide genotyping of recent isolates provided to the advisory laboratory for diagnostic reasons","volume":"305","author":"von M\u00fcller","year":"2015","journal-title":"Int. J. Med. Microbiol."},{"key":"10.1016\/j.ijmm.2021.151507_bib0190","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1128\/AAC.01820-15","article-title":"Fluoroquinolone and macrolide exposure predict Clostridium difficile infection with the highly fluoroquinolone- and macrolide-resistant epidemic C. difficile Strain BI\/NAP1\/027","volume":"60","author":"Wieczorkiewicz","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijmm.2021.151507_bib0195","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01746-18","article-title":"Role of rifampin against staphylococcal biofilm infections in vitro, in animal models, and in orthopedic-device-related infections","volume":"63","author":"Zimmerli","year":"2019","journal-title":"Antimicrob. Agents Chemother."}],"container-title":["International Journal of Medical Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1438422121000369?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1438422121000369?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T17:00:17Z","timestamp":1761411617000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1438422121000369"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S1438422121000369"],"URL":"https:\/\/doi.org\/10.1016\/j.ijmm.2021.151507","relation":{},"ISSN":["1438-4221"],"issn-type":[{"value":"1438-4221","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular epidemiology and antimicrobial resistance of Clostridioides difficile in Germany, 2014\u20132019","name":"articletitle","label":"Article Title"},{"value":"International Journal of Medical Microbiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijmm.2021.151507","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"151507"}}